Literature DB >> 16582056

Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial.

Jan Scott1, Eugene Paykel, Richard Morriss, Richard Bentall, Peter Kinderman, Tony Johnson, Rosemary Abbott, Hazel Hayhurst.   

Abstract

BACKGROUND: Efficacy trials suggest that structured psychological therapies may significantly reduce recurrence rates of major mood episodes in individuals with bipolar disorders. AIMS: To compare the effectiveness of treatment as usual with an additional 22 sessions of cognitive-behavioural therapy (CBT).
METHOD: We undertook a multicentre, pragmatic, randomised controlled treatment trial (n=253). Patients were assessed every 8 weeks for 18 months.
RESULTS: More than half of the patients had a recurrence by 18 months, with no significant differences between groups (hazard ratio=1.05; 95% CI 0.74-1.50). Post hoc analysis demonstrated a significant interaction (P=0.04) such that adjunctive CBT was significantly more effective than treatment as usual in those with fewer than 12 previous episodes, but less effective in those with more episodes.
CONCLUSIONS: People with bipolar disorder and comparatively fewer previous mood episodes may benefit from CBT. However, such cases form the minority of those receiving mental healthcare.

Entities:  

Mesh:

Year:  2006        PMID: 16582056     DOI: 10.1192/bjp.188.4.313

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  110 in total

1.  Mindfulness-based cognitive therapy for nonremitted patients with bipolar disorder.

Authors:  Thilo Deckersbach; Britta K Hölzel; Lori R Eisner; Jonathan P Stange; Andrew D Peckham; Darin D Dougherty; Scott L Rauch; Sara Lazar; Andrew A Nierenberg
Journal:  CNS Neurosci Ther       Date:  2011-04-02       Impact factor: 5.243

Review 2.  Staging bipolar disorder.

Authors:  Eduard Vieta; M Reinares; A R Rosa
Journal:  Neurotox Res       Date:  2010-05-12       Impact factor: 3.911

Review 3.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

4.  Psychotherapy for Bipolar Disorder in Adults: A Review of the Evidence.

Authors:  Holly A Swartz; Joshua Swanson
Journal:  Focus (Am Psychiatr Publ)       Date:  2014

5.  Measuring health-related quality of life in bipolar disorder: relationship of the EuroQol (EQ-5D) to condition-specific measures.

Authors:  Hazel Hayhurst; Stephen Palmer; Rosemary Abbott; Tony Johnson; Jan Scott
Journal:  Qual Life Res       Date:  2006-09-14       Impact factor: 4.147

Review 6.  Stage managing bipolar disorder.

Authors:  Michael Berk; Lesley Berk; Seetal Dodd; Sue Cotton; Craig Macneil; Rothanthi Daglas; Philippe Conus; Andreas Bechdolf; Steven Moylan; Gin S Malhi
Journal:  Bipolar Disord       Date:  2013-06-20       Impact factor: 6.744

7.  Changes in the corpus callosum in women with late-stage bipolar disorder.

Authors:  L Lavagnino; B Cao; B Mwangi; M-J Wu; M Sanches; G B Zunta-Soares; F Kapczinski; J Soares
Journal:  Acta Psychiatr Scand       Date:  2015-01-31       Impact factor: 6.392

Review 8.  The psychopathology and treatment of bipolar disorder.

Authors:  David J Miklowitz; Sheri L Johnson
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

9.  Family-focused treatment for adolescents with bipolar disorder.

Authors:  David J Miklowitz; Elizabeth L George; David A Axelson; Eunice Y Kim; Boris Birmaher; Christopher Schneck; Carol Beresford; W Edward Craighead; David A Brent
Journal:  J Affect Disord       Date:  2004-10       Impact factor: 4.839

Review 10.  A critical update on psychological interventions for bipolar disorders.

Authors:  Eduard Vieta; Isabella Pacchiarotti; Marc Valentí; Lesley Berk; Michael Berk; Jan Scott; Francesc Colom
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.